Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery
This study is currently recruiting participants.
Verified October 2012
by National Cancer Institute (NCI)
Study NCT00567931 Information provided by National Cancer Institute (NCI)
First Received on December 4, 2007. Last Updated on January 14, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
1-methyl-d-tryptophan
pharmacological study
laboratory biomarker analysis
polymorphism analysis
DNA analysis
Additional drug interventions recognized in this trial
Tryptophan
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Pharmacologic Actions
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content